MedPath

pilot clinical trial to evaluate the safety and different efficacy of different wavelength of Ellise on chronic non specific low back pai

Not Applicable
Completed
Conditions
Diseases of the musculo-skeletal system and connective tissue
Registration Number
KCT0004610
Lead Sponsor
WONTECH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
45
Inclusion Criteria

Participants meeting all of the following criteria will be included in this trial:1) male or female aged 19 to 70 years; 2) experiencing CLBP lasting for at least the previous three months; 3) Scoring = 40 points on a 100-mm VAS for pain at the time of screening; 4) Korean language fluency that is adequate for reliable completion of all study assessments; and 5) voluntary provision of informed consent.

Exclusion Criteria

The exclusion criteria are as follows: 1) Radicular pain or progressive neurological deficit; 2) diagnosis of serious spinal pathology(e.g., cancer, recent vertebral fracture, spinal infection, and inflammatory spondylitis); 3) presence of serious chronic disease (e.g., cancer, severe cardiovascular, cerebrovascular, liver, kidney disease, or diabetic neuropathy); 4) history of treatment for alcohol/drug dependency or mental diseases(e.g., schizophrenia, demetia, or epilepsy) in the six months preceding enrollment; 5) LBP is not caused by spinal or soft tissue diseases(e.g., trauma, ankylosing spondylitis, fibromyalgia, rheumatoid arthritis, or gout); 6) presence of contradictions for LA or EA, such as blood clotting abnormalities(e.g., hemophilia), severe skin disease in the lumbar region, presence of metalic device in the lumbar spine, or attaching of electronic medical device(e.g.,pacemaker); 7) Previous lumbar spinal surgery within a year or scheduled procedures during the study; 8) pregnancy or planning to become pregnant; and 9) concurrent participation in other clinical trials.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale
Secondary Outcome Measures
NameTimeMethod
Oswestry Disability Index;European Quality of Life Five Dimension. Five Level Scale
© Copyright 2025. All Rights Reserved by MedPath